"Incorporating Long-Acting Insulin Glargine Into the UVA/Padova Type 1 ..."

Roberto Visentin et al. (2019)

> Home

Details and statistics

DOI: 10.1109/TBME.2019.2897851

access: closed

type: Journal Article

metadata version: 2020-09-02

- view
  - electronic edition via DOI
  - unpaywalled version
  authority control:
- export record
  dblp key:
  - journals/tbe/VisentinSGKMC19
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/tbe/VisentinSGKMC19
Roberto Visentin, Michele Schiavon, Clemens Giegerich, Thomas Klabunde, Chiara Dalla Man, Claudio Cobelli:
Incorporating Long-Acting Insulin Glargine Into the UVA/Padova Type 1 Diabetes Simulator for In Silico Testing of MDI Therapies. IEEE Trans. Biomed. Eng. 66(10): 2889-2896 (2019)

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.